Alpha investments and securities institution

07/10/2021

30/12/2017

Silently Lycos is making strides....

Our list of India's biggest companies for 2017 is out! Find it in our latest issue, on stands right now

09/05/2016

Perfect time to buy Lycos(BSE Code-532368, CMP-18.0)?
http://alphathewealthcreator.blogspot.in/2016/05/perfect-time-to-buy-lycosbse-code.html

Disclaimer: This Blog, its owner, creator / contributor is not a research analyst and expressing opinion only as an individual investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog. Investors are advised to consult…

20/04/2016

Perfect time to buy Lycos(BSE Code-532368, CMP-19.4)?
Yes, Go guys grab it.
1. It seems that dispute with Duam regarding Lycos ownership, has been settled amicably, As Lycos internet has launched its new subsidiary cm new 'Brand' i.e. 'Brightcom Media' yesterday.
'Brightcom' is an important step to consolidate advertising business under one head, which should act as a milestone for NASDAQ listing.
2. Soon we will see full fledged launch of Lycos Life products.
3. Further there will be a launch new Lycos website soon.
Here is the link of 'Brightcom' launch-
1.http://corporates.bseindia.com/xml-data/corpfiling/AttachLive/2853192D_6920_4561_B9BA_6663DF4B649C_080321.pdf
2. http://www.moneycontrol.com/news/business/lycos-launches-subsidiary-to-focusvideo-mobile-ads_6326341.html

01/11/2015

Tanla Solution - Result Update(July'15-Sep'15)
Tanla posted decent set of numbers in Q2 of FY16 plus few exciting updates -
1. Revenue increased by 4% to 106.7cr wrt last quarter i.e. June'15 quarter.
2. Revenue increased by 108% YoY.
3. Net Pr in Q2 is 4.09cr wrt 3.13cr in Q1.
Important Observations-
1. Revenue from Core Business operations has increased by 6% from 96.5 Cr to 102.7 QoQ.
2. Profit before Tax from Core Business operations increased by 102% QoQ(wrt Q1 of FY16).
3. International A2P messaging hub is operational from Oct 2015.
4. 2 Large international clients have been boarded on the international hub in Singapore and they have started commercial traffic in October 2015.
5. India A2P messaging hub recognized as the preferred platform for delivering mission critical transactional messages like OTP’s, transaction, delivery and security alerts due to its industry leading processing times.
My view -
Singapore hub is launched in October, so traffic from that will be visible from next quarter plus they have done better in Core Business operations.
I am very positive on Tanla Solutions.
BUY at every dip is the call.

10/08/2015

Tanla Solution- Result Update
Tanla posted decent set of numbers in Q1 of FY16 -
1. Revenue increased by 17% wrt last quarter i.e. march'15 quarter.
2. Revenue increased by 150% YoY.
3. Net Pr in Q1 of FY16 was down to 3.13cr from 4.83cr last quarter(Management explained the reason clearly, it was due to higher other expenses by 6cr due to new initiatives plus lot of travelling and other expenses as they were vying for big orders).
4. Singapore hub launch delayed by 1 quarter due to change in regulatory requirement from Govt.
5 they have signed one of largest DTH operator as client under Indian A2P msging platform.
6 Earnst & Young have been signed for system security audit.

My view -
Tanla has able to grow at 17% this quarter(wrt last quarter) and 150%(wrt last year) even after delay of Singapore hub launch by a quarter.
Tanla is taking all steps to sign new clients. I am more bullish at Tanla after this result.

BUY at every dip is the call.

09/06/2015

Are we witnessing the evolution of Apple of Wearables from India in the form of Lycos Internet Ltd.?

Disclaimer: This Blog, its owner, creator / contributor is not a research analyst and expressing opinion only as an individual investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog. Investors are advised to consult…

08/06/2015

Lycos launching 'Smart Band and Smart Ring' today........

01/06/2015

Suven Life sciences-
As expected Suven has posted ordinary results as R&D expenses have increased.
On Positive side their 3rd molecule is ready for clinical trial phase, so hold on, its a long term process...........
Suven is a buy on dips........